82 related articles for article (PubMed ID: 15963952)
1. Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins.
Sung U; Jennings JL; Link AJ; Blakely RD
Biochem Biophys Res Commun; 2005 Aug; 333(3):671-8. PubMed ID: 15963952
[TBL] [Abstract][Full Text] [Related]
2. Domains necessary for Galpha12 binding and stimulation of protein phosphatase-2A (PP2A): Is Galpha12 a novel regulatory subunit of PP2A?
Zhu D; Tate RI; Ruediger R; Meigs TE; Denker BM
Mol Pharmacol; 2007 May; 71(5):1268-76. PubMed ID: 17303700
[TBL] [Abstract][Full Text] [Related]
3. A direct interaction between the N terminus of adenylyl cyclase AC8 and the catalytic subunit of protein phosphatase 2A.
Crossthwaite AJ; Ciruela A; Rayner TF; Cooper DM
Mol Pharmacol; 2006 Feb; 69(2):608-17. PubMed ID: 16258073
[TBL] [Abstract][Full Text] [Related]
4. Identification of proteins interacting with the catalytic subunit of PP2A by proteomics.
Lee WJ; Kim DU; Lee MY; Choi KY
Proteomics; 2007 Jan; 7(2):206-14. PubMed ID: 17163575
[TBL] [Abstract][Full Text] [Related]
5. Interaction of nucleoredoxin with protein phosphatase 2A.
Lechward K; Sugajska E; de Baere I; Goris J; Hemmings BA; Zolnierowicz S
FEBS Lett; 2006 Jun; 580(15):3631-7. PubMed ID: 16764867
[TBL] [Abstract][Full Text] [Related]
6. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current.
Binda F; Lute BJ; Dipace C; Blakely RD; Galli A
Neuropharmacology; 2006 Mar; 50(3):354-61. PubMed ID: 16289633
[TBL] [Abstract][Full Text] [Related]
7. Use of penetrating peptides interacting with PP1/PP2A proteins as a general approach for a drug phosphatase technology.
Guergnon J; Dessauge F; Dominguez V; Viallet J; Bonnefoy S; Yuste VJ; Mercereau-Puijalon O; Cayla X; Rebollo A; Susin SA; Bost PE; Garcia A
Mol Pharmacol; 2006 Apr; 69(4):1115-24. PubMed ID: 16387795
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes.
Dipace C; Sung U; Binda F; Blakely RD; Galli A
Mol Pharmacol; 2007 Jan; 71(1):230-9. PubMed ID: 17032905
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
Boudreau RT; Conrad DM; Hoskin DW
Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342
[TBL] [Abstract][Full Text] [Related]
10. Functional importance of the C-terminus of the human norepinephrine transporter.
Distelmaier F; Wiedemann P; Brüss M; Bönisch H
J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the protein phosphatase 2A with the regulatory domain of the cystic fibrosis transmembrane conductance regulator channel.
Vastiau A; Cao L; Jaspers M; Owsianik G; Janssens V; Cuppens H; Goris J; Nilius B; Cassiman JJ
FEBS Lett; 2005 Jun; 579(16):3392-6. PubMed ID: 15936019
[TBL] [Abstract][Full Text] [Related]
12. LIM domain protein FHL1B interacts with PP2A catalytic β subunit--a novel cell cycle regulatory pathway.
Wong CH; Fung YW; Ng EK; Lee SM; Waye MM; Tsui SK
FEBS Lett; 2010 Nov; 584(22):4511-6. PubMed ID: 20969868
[TBL] [Abstract][Full Text] [Related]
13. Structure of the protein phosphatase 2A holoenzyme.
Xu Y; Xing Y; Chen Y; Chao Y; Lin Z; Fan E; Yu JW; Strack S; Jeffrey PD; Shi Y
Cell; 2006 Dec; 127(6):1239-51. PubMed ID: 17174897
[TBL] [Abstract][Full Text] [Related]
14. Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells.
Teruya T; Simizu S; Kanoh N; Osada H
FEBS Lett; 2005 Apr; 579(11):2463-8. PubMed ID: 15848189
[TBL] [Abstract][Full Text] [Related]
15. Impaired development of the Harderian gland in mutant protein phosphatase 2A transgenic mice.
Schild A; Isenmann S; Tanimoto N; Tonagel F; Seeliger MW; Ittner LM; Kretz A; Ogris E; Götz J
Mech Dev; 2006 May; 123(5):362-71. PubMed ID: 16679006
[TBL] [Abstract][Full Text] [Related]
16. Physical association of GPR54 C-terminal with protein phosphatase 2A.
Evans BJ; Wang Z; Mobley L; Khosravi D; Fujii N; Navenot JM; Peiper SC
Biochem Biophys Res Commun; 2008 Dec; 377(4):1067-71. PubMed ID: 18977201
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration.
Kiely PA; O'Gorman D; Luong K; Ron D; O'Connor R
Mol Cell Biol; 2006 Jun; 26(11):4041-51. PubMed ID: 16705158
[TBL] [Abstract][Full Text] [Related]
18. Identification of PP2A as a novel interactor and regulator of TRIP-Br1.
Zang ZJ; Gunaratnam L; Cheong JK; Lai LY; Hsiao LL; O'Leary E; Sun X; Salto-Tellez M; Bonventre JV; Hsu SI
Cell Signal; 2009 Jan; 21(1):34-42. PubMed ID: 18940248
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor.
Vera J; Jaumot M; Estanyol JM; Brun S; Agell N; Bachs O
Oncogene; 2006 Jan; 25(2):260-70. PubMed ID: 16170352
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the C-terminal leucine residue of the PP2A catalytic subunit is unnecessary for the catalytic activity and the binding of regulatory subunit (PR55/B).
Ikehara T; Ikehara S; Imamura S; Shinjo F; Yasumoto T
Biochem Biophys Res Commun; 2007 Mar; 354(4):1052-7. PubMed ID: 17274953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
